Conor Walsh

Forecasting, Insights & Analytics Leader, Global Cvrm Early Assets Business Development @阿斯利康

London, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2020 — Present

Forecasting, Insights & Analytics Leader, Global Cvrm Early Assets Business Development @阿斯利康

View department →

Cambridge, GB

Forecasting Leader in the Cardiovascular, Renal, and Metabolic (CVRM) Disorders Early Assets team, providing forecasting and global insights & analytics support for pipeline assets. I work as a strategic partner for clinical and commercial development efforts, helping to support informed and strategic decision-making activities, such as clinical investment and business development activities.

EDUCATION

2005 — 2009

The University of Manchester

PhD, Cardiovascular Medicine

2003 — 2004

The University of Manchester

MSc, Bioinformatics

1998 — 2002

University of Galway

BSc, Biotechnology

SKILLS

BiotechnologyMarket AnalysisBiochemistryMarket ResearchCompetitive IntelligenceLifesciencesCompetitive AnalysisData AnalysisImmunologyManagementMarket AccessHealthcareBioinformaticsMarketing ResearchOncologyCardiovascular DiseaseMetabolismCardiovascular MedicinePharmaceutical IndustryLife Sciences

ABOUT CONOR WALSH

Forecasting, Insights & Analytics Leader, Global CVRM Early Assets / Business Development at AstraZeneca

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Conor Walsh — Forecasting, Insights & Analytics Leader, Global Cvrm Early Assets Business Development at 阿斯利康 in London, GB | Unifers